(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2 Ucoceko > 99.0%(GC) Afatinib Amprenavir Fosamprenavir Umfanekiso oPhakathi oFakelweyo

(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2 Ucoceko > 99.0%(GC) Afatinib Amprenavir Fosamprenavir Intermediate

Inkcazelo emfutshane:

Igama leMichiza: (S) -3-Hydroxytetrahydrofuran

CAS: 86087-23-2

IColerless Transparent to Light Yellwow Liquid

Ubunyulu: >99.0%(GC) Ucoceko olubonakalayo: >99.0% (GC)

Umbindi weAfatinib, Amprenavir, Fosamprenavir

Inquiry: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo lwabavelisi;Imveliso eshushu;Ukucoceka okuphezulu kunye neXabiso loKhuphiswano
(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2
Afatinib CAS 439081-18-2,Afatinib Dimaleate CAS 850140-73-7Engundoqo oPhakathi
Amprenavir (CAS 161814-49-9) kunye neFosamprenavir (CAS 226700-79-4) ePhakathi

Iipropati zeMichiza:

Igama leMchiza	(S) -3-Hydroxytetrahydrofuran
Izithethantonye	(S)-(+)-3-Hydroxytetrahydrofuran;(S)-Tetrahydrofuran-3-ol;(S)-(+)-Tetrahydro-3-Furanol
Inombolo yeCAS	86087-23-2
Inombolo yeCAT	RF-CC101
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	C₄H₈O₂
Ubunzima beMolekyuli	88.11
Indawo yokubilisa	80℃/15 mmHg(lit.)
Ukuxinana	1.103 g/mL ku-25℃ (lit.)
Refractive Index	n20/D 1.45 (lit.)
Ukunyibilika kwamanzi	Enyibilikayo
Imeko yokuthumela ngenqanawa	Ithunyelwe Ngaphantsi Kweqondo Lobushushu Le-Ambient
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	IColerless Transparent to Light Yellwow Liquid
Ubunyulu / Indlela yokuHlalutya	>99.0% (GC)
Ukuchongwa	Ixesha lokugcinwa kwesampulu kufuneka lihambelane nexesha lokugcinwa komgangatho wereferensi
Ukujikeleziswa okuthe ngqo[α]_D²⁰	+17.5° ± 2.5° (C=2 kwi-MeOH)
Ukucoceka kwamehlo	Ewe >99.0% (GC)
Ukufuma (KF)	<0.50%
(R)-(-)-3-Hydroxytetrahydrofuran	<0.15%
Nakuphi na Okunye Ukungcola Okukodwa	<0.40%
Ukungcola okupheleleyo	<1.00%
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	Umbindi weAfatinib, Afatinib Dimaleate, Amprenavir kunye neAmprenavir Phosphate

(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2 ROS

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, iFluoride Barels, 25kg/Barel, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.

Izinto eziluncedo:

Umthamo owaneleyo: Izixhobo ezaneleyo kunye namagcisa

Inkonzo yobuNgcali: Inkonzo enye yokuyeka ukuthenga

Ipakethe ye-OEM: Iphakheji yesiko kunye neleyibhile ekhoyo

Ukuhanjiswa ngokukhawuleza: Ukuba ngaphakathi kwesitokhwe, ukuhanjiswa kweentsuku ezintathu kuqinisekisiwe

Ubonelelo oluzinzileyo: Gcina isitokhwe esifanelekileyo

Inkxaso yobuGcisa: Isisombululo seTekhnoloji siyafumaneka

Inkonzo yesiNtu yoHlanganiso: Isuka kwiigram ukuya kwiikhilos

Umgangatho ophezulu: Kusekwe inkqubo epheleleyo yokuqinisekisa umgangatho

FAQ:

Isicelo:

I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi (S)-(+)-3-Hydroxytetrahydrofuran (CAS: 86087-23-2) enomgangatho ophezulu, esetyenziswa ngokubanzi kwi-synthesis ye-pharmaceutical intermediates kunye ne-Active Pharmaceutical Isithako (API).(S)-(+)-3-Hydroxytetrahydrofuran yeyona nto iphakathi kwe-Afatinib (CAS 439081-18-2), i-Afatinib Dimaleate (CAS: 850140-73-7), i-Amprenavir (CAS 161814-49-9) kunye neFosamprenavir ( I-CAS 226700-79-4).I-Afatinib (i-CAS 439081-18-2) inamandla, i-covalent / ayinakuguqulwa, kunye ne-oral bioavailable dual (EGFR / ErbB) i-receptor tyrosine kinase (RTK) inhibitor kunye nomsebenzi we-anticancer.I-Afatinib (i-CAS 439081-18-2) iyeza elimiselweyo elinokuthi lithathwe ngomlomo ukwenzela unyango lwe-non-small cell lung cancer (NSCLC) kunye ne-atypical Epidermal Growth Factor Receptor (EFGR) agents.I-Amprenavir (CAS 161814-49-9) yi-HIV protease inhibitor esetyenziselwa ukunyanga usulelo lwe-HIV.I-Amprenavir ikwayi-SARS-CoV 3CLpro inhibitor ene-IC50 ye-1.09 μM.I-Fosamprenavir (i-Amprenavir phosphate; GW 433908) yi-phosphate ester prodrug ye-antiretroviral protease inhibitor i-Amprenavi.